đŹ Current Disease Focus:
Task Progress: 0%
đ„ Active Problem Solvers
0
đ Experts collaborating globally
⥠Current Task Assignment
𧏠Genetic Analysis
đ Matching experts to specific tasks
đ Resource Allocation by Research Phase:
đ Data Analysis
đ§Ș Experimental Design
đŹ Clinical Trials
đ Treatment Development
The objective of the current study is to investigate the efficacy, safety a...
Status
Completed
Location
1218.20.10033 Boehringer Ingelheim Investigational Site
Start Date
2008-02
Trial ID
NCT00622284
The objective of the study is to test the efficacy, safety and tolerability...
Status
Completed
Location
1218.6.3302A Boehringer Ingelheim Investigational Site
Start Date
2006-04
Trial ID
NCT00309608
Treatments Being Tested
The objective of the current study is to investigate the efficacy, safety a...
Status
Completed
Location
1218.18.54001 Boehringer Ingelheim Investigational Site
Start Date
2008-02
Trial ID
NCT00602472
Treatments Being Tested
to determine safety, efficacy and tolerability of BI 1356 versus placebo...
Status
Completed
Location
1218.43.10027 Boehringer Ingelheim Investigational Site
Start Date
2008-12
Trial ID
NCT00800683
Efficacy and safety of BI 1356 compared to placebo in patients with type 2 ...
Status
Completed
Location
1218.35.10002 Boehringer Ingelheim Investigational Site
Start Date
2008-12
Trial ID
NCT00819091
The objective of the current study is to investigate the efficacy, safety a...
Status
Completed
Location
1218.17.10003 Boehringer Ingelheim Investigational Site
Start Date
2008-01
Trial ID
NCT00601250
Treatments Being Tested
The objective of the current study was to investigate safety, tolerability,...
Status
Completed
Location
Multiple Locations
Start Date
2004-10
Trial ID
NCT02173665
Treatments Being Tested
To investigate the food effect on the relative bioavailability and pharmaco...
Status
Completed
Location
Multiple Locations
Start Date
2008-10
Trial ID
NCT02183493
Treatments Being Tested
Study to investigate the safety, tolerability, pharmacokinetics, and pharma...
Status
Completed
Location
Multiple Locations
Start Date
2005-08
Trial ID
NCT02183415
Treatments Being Tested
Study to investigate the relative bioavailability of 5 mg BI 1356 as tablet...
Status
Completed
Location
Multiple Locations
Start Date
2007-02
Trial ID
NCT02183363
Treatments Being Tested